Background: Pain is a common complication after stroke and is associated with the presence of depression, cognitive dysfunction, and impaired quality of life. It remains underdiagnosed and undertreated, despite evidence that effective treatment of pain may improve function and quality of life. Summary: We provide an overview of the means for clinical assessment and risk factors for the development of post-stroke pain, then review the newest available literature regarding the commonest post-stroke pain syndromes, including central post-stroke pain, complex regional pain syndrome, musculoskeletal pain including shoulder subluxation, spasticity-related pain, and post-stroke headache, as well as the available epidemiology and current treatment options. Key Messages: In the best interests of optimizing quality of life and function after stroke, clinicians should be aware of pain as a common complication after stroke, identify those patients at highest risk, directly inquire as to the presence and characteristics of pain, and should be aware of the options for treatment for the various pain syndromes.

Keywords:
Stroke, Pain, Complications, Therapy, Quality of life, Spasticity, Central post-stroke pain, Complex regional pain syndrome, Shoulder subluxation
1.
Naess H, Lunde L, Brogger J: The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the bergen stroke study. Vasc Health Risk Manag 2012;8:407-413.
2.
Klit H, Finnerup NB, Andersen G, Jensen TS: Central poststroke pain: a population-based study. Pain 2011;152:818-824.
3.
Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al: Medical complications after stroke: a multicenter study. Stroke 2000;31:1223-1229.
4.
Widar M, Samuelsson L, Karlsson-tivenius S, Ahlstrom G: Long-term pain conditions after a stroke. J Rehabil Med 2002;34:165-170.
5.
O'Donnell MJ, Diener HC, Sacco RL, Panju AA, Vinisko R, Yusuf S: Chronic pain syndromes after ischemic stroke: PRoFESS trial. Stroke 2013;44:1238-1243.
6.
Hoang CL, Salle JY, Mandigout S, Hamonet J, Macian-Montoro F, Daviet JC: Physical factors associated with fatigue after stroke: an exploratory study. Top Stroke Rehabil 2012;19:369-376.
7.
Lundström E, Smits A, Terént A, Borg J: Risk factors for stroke-related pain 1 year after first-ever stroke. Eur J Neurol 2009;16:188-193.
8.
Tang WK, Liang H, Mok V, Ungvari GS, Wong KS: Is pain associated with suicidality in stroke? Arch Phys Med Rehabil 2013;94:863-866.
9.
Jonsson AC, Lindgren I, Hallstrom B, Norrving B, Lindgren A: Prevalence and intensity of pain after stroke: a population based study focusing on patients' perspectives. J Neurol Neurosurg Psychiatry 2006;77:590-595.
10.
Moriarty O, McGuire BE, Finn DP: The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 2011;93:385-404.
11.
Okada K, Murase K, Kawakita K: Effects of electrical stimulation of thalamic nucleus submedius and periaqueductal gray on the visceral nociceptive responses of spinal dorsal horn neurons in the rat. Brain Res 1999;834:112-121.
12.
Bair MJ, Robinson RL, Katon W, Kroenke K: Depression and pain comorbidity: a literature review. Arch Intern Med 2014;163:2433-2445.
13.
Park DC, Glass JM, Minear M, Crofford LJ: Cognitive function in fibromyalgia patients. Arthritis Rheum 2001;44:2125-2133.
14.
Hu Y, Yang J, Hu Y, Wang Y, Li W: Amitriptyline rather than lornoxicam ameliorates neuropathic pain-induced deficits in abilities of spatial learning and memory. Eur J Anaesthesiol 2010;27:162-168.
15.
Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP: Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003;26:913-921.
16.
Ehrich EW, Bolognese JA, Watson DJ, Kong SX: Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis. Am J Manag Care 2001;7:609-616.
17.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-1842.
18.
Katz N: The impact of pain management on quality of life. J Pain Symptom Manage 2002;24(1 suppl):S38-S47.
19.
McCarberg BH, Barkin RL: Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 2001;8:181-186.
20.
Bowsher D: The management of central post-stroke pain. Postgrad Med J 1995;71:598-604.
21.
Sommerfeld DK, Welmer AK: Pain following stroke, initially and at 3 and 18 months after stroke, and its association with other disabilities. Eur J Neurol 2012;19:1325-1330.
22.
Weiner DK, Rudy TE: Attitudinal barriers to effective treatment of persistent pain in nursing home residents. J Am Geriatr Soc 2002;50:2035-2040.
23.
Catananti C, Gambassi G: Pain assessment in the elderly. Surg Oncol 2010;19:140-148.
24.
Smith JH, Bottemiller KL, Flemming KD, Michael Cutrer F, Strand EA: Inability to self-report pain after a stroke: a population-based study. Pain 2013;154:1281-1286.
25.
Price CI, Curless RH, Rodgers H: Can stroke patients use visual analogue scales? Stroke 1999;30:1357-1361.
26.
Benaim C, Froger J, Cazottes C, Gueben D, Porte M, Desnuelle C, et al: Use of the faces pain scale by left and right hemispheric stroke patients. Pain 2007;128:52-58.
27.
Pain terms: a current list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain 1979;6:S215-S221.
28.
Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS: Incidence of central post-stroke pain. Pain 1995;61:187-193.
29.
Kumar G, Soni CR: Central post-stroke pain: current evidence. J Neurol Sci 2009;284:10-17.
30.
Hansson P: Post-stroke pain case study: clinical characteristics, therapeutic options and long-term follow-up. Eur J Neurol 2004;11(suppl 1):22-30.
31.
Klit H, Finnerup NB, Jensen TS: Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 2009;8:857-868.
32.
Acerra NE, Souvlis T, Moseley GL: Stroke, complex regional pain syndrome and phantom limb pain: can commonalities direct future management? J Rehabil Med 2007;39:109-114.
33.
Hansen AP, Marcussen NS, Klit H, Andersen G, Finnerup NB, Jensen TS: Pain following stroke: a prospective study. Eur J Pain 2012;16:1128-1136.
34.
Canavero S, Bonicalzi V: Central Pain of Brain Origin: Epidemiology and Clinical Features. Cambridge University Press, 2007, pp 9-99.
35.
Leijon G, Boivie J, Johansson I: Central post-stroke pain - neurological symptoms and pain characteristics. Pain 1989;36:13-25.
36.
Harno H, Haapaniemi E, Putaala J, Haanpaa M, Makela JP, Kalso E, et al: Central poststroke pain in young ischemic stroke survivors in the Helsinki young stroke registry. Neurology 2014;83:1147-1154.
37.
Tasker RR: Microelectrode findings in the thalamus in chronic pain and other conditions. Stereotact Funct Neurosurg 2001;77:166-168.
38.
Nasreddine ZS, Saver JL: Pain after thalamic stroke: right diencephalic predominance and clinical features in 180 patients. Neurology 1997;48:1196-1199.
39.
Bassetti C, Bogousslavsky J, Regli F: Sensory syndromes in parietal stroke. Neurology 1993;43:1942-1949.
40.
Merskey H, Watson GD: The lateralisation of pain. Pain 1979;7:271-280.
41.
Hall W, Clark IM: Pain and laterality in a British pain clinic sample. Pain 1982;14:63-66.
42.
Benavente OR, Pearce LA, Bazan C, Roldan AM, Catanese L, Bhat Livezey VM, et al: Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. Int J Stroke 2014;9:1057-1064.
43.
Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, et al: Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000;54:564-574.
44.
Vick PG, Lamer TJ: Treatment of central post-stroke pain with oral ketamine. Pain 2001;92:311-313.
45.
Lampl C, Yazdi K, Roper C: Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study. Stroke 2002;33:3030-3032.
46.
Pellicane AJ, Millis SR: Efficacy of methylprednisolone versus other pharmacologic interventions for the treatment of central post-stroke pain: a retrospective analysis. J Pain Res 2013;6:557-563.
47.
Cruccu G, Aziz TZ, Garcia-Larrea L, Hansson P, Jensen TS, Lefaucheur JP, et al: EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007;14:952-970.
48.
Nguyen JP, Lefaucheur JP, Decq P, Uchiyama T, Carpentier A, Fontaine D, et al: Chronic motor cortex stimulation in the treatment of central and neuropathic pain. Correlations between clinical, electrophysiological and anatomical data. Pain 1999;82:245-251.
49.
Rasche D, Rinaldi PC, Young RF, Tronnier VM: Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus 2006;21:E8.
50.
Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC: Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005;76:833-838.
51.
McGeoch PD, Williams LE, Lee RR, Ramachandran VS: Behavioural evidence for vestibular stimulation as a treatment for central post-stroke pain. J Neurol Neurosurg Psychiatry 2008;79:1298-1301.
52.
Malhotra S, Pandyan AD, Day CR, Jones PW, Hermens H: Spasticity, an impairment that is poorly defined and poorly measured. Clin Rehabil 2009;23:651-658.
53.
Wissel J, Schelosky LD, Scott J, Christe W, Faiss JH, Mueller J: Early development of spasticity following stroke: a prospective, observational trial. J Neurol 2010;257:1067-1072.
54.
Sheean DG: Is spasticity painful? Eur J Neurol 2009;16:157-158.
55.
Hosomi K, Saitoh Y, Kishima H, Oshino S, et al: Electrical stimulation of primary motor cortex within the central sulcus for intractable neuropathic pain. Clin Neurophysiol 2008;119:993-1001.
56.
Dietz V, Sinkjaer T: Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007;6:725-733.
57.
Truini A, Barbanti P, Pozzilli C, Cruccu G: A mechanism-based classification of pain in multiple sclerosis. J Neurol 2013;260:351-367.
58.
Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK, Watkins CL: Predicting spasticity after stroke in those surviving to 12 months. Clin Rehabil 2004;18:438-443.
59.
Wood DE, Burridge JH, van Wijck FM, McFadden C, Hitchcock RA, Pandyan AD, et al: Biomechanical approaches applied to the lower and upper limb for the measurement of spasticity: a systematic review of the literature. Disabil Rehabil 2005;27:19-32.
60.
Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S: Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013;6:CD009689.
61.
Baker JA, Pereira G: The efficacy of botulinum toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the grades of recommendation, assessment, development and evaluation approach. Clin Rehabil 2013;27:1084-1096.
62.
Bakheit AM: The pharmacological management of post-stroke muscle spasticity. Drugs Aging 2012;29:941-947.
63.
Gold R, Oreja-Guevara C: Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines. Expert Rev Neurother 2013;13:55-59.
64.
Graham LA: Management of spasticity revisited. Age Ageing 2013;42:435-441.
65.
Sunnerhagen KS, Olver J, Francisco GE: Assessing and treating functional impairment in poststroke spasticity. Neurology 2013;80(3 suppl 2):S35-S44.
66.
Thibaut A, Chatelle C, Ziegler E, Bruno MA, Laureys S, Gosseries O: Spasticity after stroke: physiology, assessment and treatment. Brain Inj 2013;27:1093-1105.
67.
Gamble GE, Barberan E, Bowsher D, Tyrrell PJ, Jones AK: Post stroke shoulder pain: more common than previously realized. Eur J Pain 2000;4:313-315.
68.
Roy CW, Sands MR, Hill LD: Shoulder pain in acutely admitted hemiplegics. Clin Rehabil 1994;8:334-340.
69.
Gamble GE, Barberan E, Laasch HU, Bowsher D, Tyrrell PJ, Jones AK: Poststroke shoulder pain: a prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke. Eur J Pain 2002;6:467-474.
70.
Dromerick A, Reding M: Medical and neurological complications during inpatient stroke rehabilitation. Stroke 1994;25:358-361.
71.
Dromerick AW, Edwards DF, Kumar A: Hemiplegic shoulder pain syndrome: frequency and characteristics during inpatient stroke rehabilitation. Arch Phys Med Rehabil 2008;89:1589-1593.
72.
Lindgren I, Jönsson AC, Norrving B, Lindgren A: Shoulder pain after stroke: a prospective population-based study. Stroke 2007;38:343-348.
73.
Rajaratnam BS, Venketasubramanian N, Kumar PV, Goh JC, Chan YH: Predictability of simple clinical tests to identify shoulder pain after stroke. Arch Phys Med Rehabil 2007;88:1016-1021.
74.
Van Ouwenaller C, Laplace PM, Chantraine A: Painful shoulder in hemiplegia. Arch Phys Med Rehabil 1986;67:23-26.
75.
Poulin de Courval L, Barsauskas A, Berenbaum B, Dehaut F, Dussault R, Fontaine FS, et al: Painful shoulder in the hemiplegic and unilateral neglect. Arch Phys Med Rehabil 1990;71:673-676.
76.
Faghri PD, Rodgers MM, Glaser RM, Bors JG, Ho C, Akuthota P: The effects of functional electrical stimulation on shoulder subluxation, arm function recovery, and shoulder pain in hemiplegic stroke patients. Arch Phys Med Rehabil 1994;75:73-79.
77.
Paci M, Nannetti L, Taiti P, et al: Shoulder subluxation after stroke: relationships with pain and motor recovery. Physiother Res Int 2007;12:95-104.
78.
Chino N: Electrophysiological investigation on shoulder subluxation in hemiplegics. Scand J Rehabil Med 1981;13:17-21.
79.
Dawson AS, Knox J, McClure A, Foley N, Teasell R; Stroke Rehabilitation Best Practices Writing Group: Management of shoulder pain following stroke; in Lindsay MP, Gubitz G, Bayley M, Phillips S (eds): Canadian Best Practice Recommendations for Stroke Care. Ottawa, Ontario, Canada, Heart and Stroke Foundation and the Canadian Stroke Network, 2013, pp 47-50.
80.
Vasudevan JM, Browne BJ: Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am 2014;25:411-437.
81.
Zorowitz RD: Recovery patterns of shoulder subluxation after stroke: a six-month follow-up study. Top Stroke Rehabil 2001;8:1-9.
82.
Garrison DW, Foreman RD: Decreased activity of spontaneous and noxiously evoked dorsal horn cells during transcutaneous electrical nerve stimulation (TENS). Pain 1994;58:309-315.
83.
Linn SL, Granat MH, Lees KR: Prevention of shoulder subluxation after stroke with electrical stimulation. Stroke 1999;30:963-968.
84.
Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA: Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996;61:30-35.
85.
Sackley C, Brittle N, Patel S, Ellins J, Scott M, Wright C, et al: The prevalence of joint contractures, pressure sores, painful shoulder, other pain, falls, and depression in the year after a severely disabling stroke. Stroke 2008;39:3329-3334.
86.
Kwah LK, Harvey LA, Diong JH, Herbert RD: Half of the adults who present to hospital with stroke develop at least one contracture within six months: an observational study. J Physiother 2012;58:41-47.
87.
Katalinic OM, Harvey LA, Herbert RD: Effectiveness of stretch for the treatment and prevention of contractures in people with neurological conditions: a systematic review. Phys Ther 2014;91:11-24.
88.
Malhotra S, Rosewilliam S, Hermens H, Roffe C, Jones P, Pandyan AD: A randomized controlled trial of surface neuromuscular electrical stimulation applied early after acute stroke: effects on wrist pain, spasticity and contractures. Clin Rehabil 2013;27:579-590.
89.
Yu DT: Shoulder pain and other musculoskeletal complications; in Stein J, Harvey RL, Macko RF, Winstein CJ, Zorowitz RD (eds): Stroke Recovery and Rehabilitation. New York, DemosMedical, 2009, pp 437-451.
90.
McLean DE: Medical complications experienced by a cohort of stroke survivors during inpatient, tertiary-level stroke rehabilitation. Arch Phys Med Rehabil 2004;85:466-469.
91.
Kocabas H, Levendoglu F, Ozerbil OM, Yuruten B: Complex regional pain syndrome in stroke patients. Int J Rehabil Res 2007;30:33-38.
92.
Harden RN, Bruehl S, Galer BS, Saltz S, Bertram M, Backonja M, et al: Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 1999;83:211-219.
93.
Harden RN, Bruehl SP: Complex Regional Pain Syndrome: Treatment Guidelines. Milford, CT, RSDSA Press, 2006.
94.
Dursun E, Dursun N, Ural CE, Cakci A: Glenohumeral joint subluxation and reflex sympathetic dystrophy in hemiplegic patients. Arch Phys Med Rehabil 2000;81:944-946.
95.
Gokkaya NK, Aras M, Yesiltepe E, Koseoglu F: Reflex sympathetic dystrophy in hemiplegia. Int J Rehabil Res 2006;29:275-279.
96.
Chae J: Poststroke complex regional pain syndrome. Top Stroke Rehabil 2010;17:151-162.
97.
Fukumoto M, Ushida T, Zinchuk VS, Yamamoto H, Yoshida S: Contralateral thalamic perfusion in patients with reflex sympathetic dystrophy syndrome. Lancet 1999;354:1790-1791.
98.
Juottonen K, Gockel M, Silén T, Hurri H, Hari R, Forss N: Altered central sensorimotor processing in patients with complex regional pain syndrome. Pain 2002;98:315-323.
99.
Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M: Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain 2006;22:235-239.
100.
Okudan B, Celik C: Determination of inflammation of reflex sympathetic dystrophy at early stages with Tc-99m HIG scintigraphy: preliminary results. Rheumatol Int 2006;26:404-408.
101.
Koban M, Leis S, Schultze-Mosgau S, Birklein F: Tissue hypoxia in complex regional pain syndrome. Pain 2003;104:149-157.
102.
Heerschap A, den Hollander JA, Reynen H, Goris RJ: Metabolic changes in reflex sympathetic dystrophy: a 31P NMR spectroscopy study. Muscle Nerve 1993;16:367-373.
103.
Kozin F, Genant HK, Bekerman C, McCarty DJ: The reflex sympathetic dystrophy syndrome. II. Roentgenographic and scintigraphic evidence of bilaterality and of periarticular accentuation. Am J Med 1976;60:332-338.
104.
Sambrook P, Champion GD: Reflex sympathetic dystrophy; characteristic changes in bone on CT scan. J Rheumatol 1990;17:1425-1426.
105.
Schweitzer ME, Mandel S, Schwartzman RJ, Knobler RL, Tahmoush AJ: Reflex sympathetic dystrophy revisited: MR imaging findings before and after infusion of contrast material. Radiology 1995;195:211-214.
106.
Pertoldi S, Di Benedetto P: Shoulder-hand syndrome after stroke. A complex regional pain syndrome. Eura Medicophys 2005;41:283-292.
107.
Kondo I, Hosokawa K, Soma M, Iwata M, Maltais D: Protocol to prevent shoulder-hand syndrome after stroke. Arch Phys Med Rehabil 2001;82:1619-1623.
108.
Wasner G, Schattschneider J, Binder A, Baron R: Complex regional pain syndrome - diagnostic, mechanisms, CNS involvement and therapy. Spinal Cord 2003;41:61-75.
109.
Harden RN: Complex regional pain syndrome. Br J Anaesth 2001;87:99-106.
110.
Altschuler EL, Wisdom SB, Stone L, Foster C, Galasko D, Llewellyn DME, et al: Rehabilitation of hemiparesis after stroke with a mirror: early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999;353:2036-2037.
111.
Gierthmuhlen J, Binder A, Baron R: Mechanism-based treatment in complex regional pain syndromes. Nat Rev Neurol 2014;10:518-528.
112.
Lohnberg JA, Altmaier EM: A review of psychosocial factors in complex regional pain syndrome. J Clin Psychol Med Settings 2013;20:247-254.
113.
Sinis N, Birbaumer N, Gustin S, Schwarz A, Bredanger S, Becker ST, et al: Memantine treatment of complex regional pain syndrome: a preliminary report of six cases. Clin J Pain 2007;23:237-243.
114.
van de Vusse AC, Stomp-van den Berg SG, Kessels AH, Weber WE: Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [ISRCTN84121379]. BMC Neurol 2004;4:13.
115.
Harke H, Gretenkort P, Ladleif HU, Harke O: The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth Analg 2001;92:488-495.
116.
Kingery WS: A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-139.
117.
Robinson JN, Sandom J, Chapman PT: Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 2004;5:276-280.
118.
Kalita J, Vajpayee A, Misra UK: Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM 2006;99:89-95.
119.
Christensen K, Jensen EM, Noer I: The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand 1982;148:653-655.
120.
Braus DF, Krauss JK, Strobel J: The shoulder-hand syndrome after stroke: a prospective clinical trial. Ann Neurol 1994;36:728-733.
121.
Arboix A, Massons J, Oliveres M, Arribas MP, Titus F: Headache in acute cerebrovascular disease: a prospective clinical study in 240 patients. Cephalalgia 1994;14:37-40.
122.
Widar M, Ahlström G, Ek AC: Health-related quality of life in persons with long-term pain after a stroke. J Clin Nurs 2004;13:497-505.
123.
Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.